A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients With Advanced Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-1214
Full Text
Open PDFAbstract
Available in full text
Date
November 3, 2009
Authors
Publisher
American Association for Cancer Research (AACR)